Filament Health Corp (NEO:FH, OTCQB:FLHLF) has postponed its Special Meeting to December 18, to restructure financing terms for senior secured convertible notes, ensuring NASDAQ listing compliance. The amended Note Financing terms, aimed at meeting NASDAQ requirements, will be announced before the reconvened meeting. Jeremy Weech, Helena Managing Partner, expresses anticipation for collaborative efforts with Filament and Jupiter teams to structure investment terms for compliance with all parties, including NASDAQ exchange.
The Markets by Proactive
Go to Proactive Australia
Proactive’s Australian coverage continues on .com